SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-20-000010
Filing Date
2020-03-12
Accepted
2020-03-12 16:10:36
Documents
3
Period of Report
2020-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kearningsrelease122019.htm 8-K 27829
2 EXHIBIT 99.1 ex991earningsrelease122019.htm EX-99.1 105856
3 imagea07.jpg GRAPHIC 5087
  Complete submission text file 0000891293-20-000010.txt   142033
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 20708861
SIC: 2834 Pharmaceutical Preparations